Neptune Wellness Solutions announced the Company’s Board of Directors has named Board member Michael De Geus Interim President and CEO, effective immediately. Mr. De Geus has served as an integral member of the previously disclosed Restructuring Committee of the Board of Directors following the furlough and departure of Michael Cammarata, who served as President and CEO since 2019. Additionally, the Company’s Board of Directors has named Cedrick Billequey, currently General Manager of Neptune’s subsidiary Biodroga Nutraceuticals, Interim COO of Neptune. He will continue his role at Biodroga concurrently with his interim appointment.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NEPT:
- Neptune Wellness Faces Nasdaq Delisting, Considers OTCQB Move
- Neptune Wellness announces decision of Nasdaq Hearings Panel to delist shares
- Neptune Wellness CEO Michael Cammarata resigns
- Neptune Wellness Executives on Unpaid Leave Amid Restructuring
- Neptune Wellness places certain employees on mandatory unpaid leave of absence
